Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients.
about
Managing drug interactions in HIV-infected adults with comorbid illnessLongitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisonsImportant Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.Psychotropic drug-drug interactions involving P-glycoprotein.The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.Clinically significant drug interactions with atypical antipsychotics.Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.Gold(I) complex of 1,1'-bis(diphenylphosphino) ferrocene-quinoline conjugate: a virostatic agent against HIV-1.Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor.
P2860
Q26825406-6B0C2C97-C81C-4283-9E4A-39472B40BB09Q36462000-B9DAD067-C66F-4947-89B7-74A2DD1143B9Q37962449-89B8065C-9DFC-4F89-A0F1-3DF6D724232DQ38047816-93A6765C-7120-4180-8AB9-E232B56C5E58Q38152774-739509EE-9277-4C59-B129-702FCCC94058Q38156416-3B1B04E2-83A6-4B23-A0A8-26DC69FD09F3Q38435908-CBC04DD5-3CED-41C1-AE02-4EE0C94604C7Q38734067-536784BC-54C4-4B24-8F67-C6FFBD10E73FQ39963331-D6828067-406F-4EDB-AF31-9D278C4F5C73Q43041164-357D04EA-116F-48A4-9529-75CFFCC61414
P2860
Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Clinically significant adverse ...... vir-ritonavir in two patients.
@en
Clinically significant adverse ...... vir-ritonavir in two patients.
@nl
type
label
Clinically significant adverse ...... vir-ritonavir in two patients.
@en
Clinically significant adverse ...... vir-ritonavir in two patients.
@nl
prefLabel
Clinically significant adverse ...... vir-ritonavir in two patients.
@en
Clinically significant adverse ...... vir-ritonavir in two patients.
@nl
P2093
P2860
P356
P1433
P1476
Clinically significant adverse ...... vir-ritonavir in two patients.
@en
P2093
Christopher McCoy
Todd M Pollack
Wendy Stead
P2860
P304
P356
10.1592/PHCO.29.11.1386
P407
P577
2009-11-01T00:00:00Z